| 注册
首页|期刊导航|中国全科医学|美国心脏协会指南解读系列

美国心脏协会指南解读系列

周伊恒 杨梓钰 吕垚 刘力滴 沈灿 廖晓阳 贾禹

中国全科医学2024,Vol.27Issue(35):4353-4357,5.
中国全科医学2024,Vol.27Issue(35):4353-4357,5.DOI:10.12114/j.issn.1007-9572.2024.0192

美国心脏协会指南解读系列

Interpretation of the Use of Artificial Intelligence in Improving Outcomes in Heart Disease:a Scientific Statement from the American Heart Association

周伊恒 1杨梓钰 1吕垚 1刘力滴 1沈灿 1廖晓阳 1贾禹1

作者信息

  • 1. 610041 四川省成都市,四川大学华西医院全科医学中心全科医学教研室全科医学研究室
  • 折叠

摘要

Abstract

Artificial Intelligence(AI)is an emerging technology to improve healthcare services.With the joint promotion of government agencies and academic departments around the world,a large number of studies have demonstrated that AI can improve the diagnosis,treatment and prevention of cardiovascular disease.However,there are still some limitations in its development and application,and it has not yet been widely used in clinical practice.Based on this,the American Heart Association(AHA)published the Use of Artificial Intelligence in Improving Outcomes in Heart Disease:a Scientific Statement from the American Heart Association in Circulation on April 2,2024.This statement reviews the research progress of AI in the diagnosis,classification and treatment of cardiovascular disease,puts forward the existing problems and potential solutions,and builds a framework for the future application of AI in the cardiovascular disease.This article aims to interpret the statement for providing advice and direction for the application and research of AI in cardiovascular disease in China.

关键词

人工智能/心血管疾病/科学声明/解读/美国心脏协会

Key words

Artificial intelligence/Cardiovascular diseases/Scientific statement/Interpretation/American Heart Association

分类

医药卫生

引用本文复制引用

周伊恒,杨梓钰,吕垚,刘力滴,沈灿,廖晓阳,贾禹..美国心脏协会指南解读系列[J].中国全科医学,2024,27(35):4353-4357,5.

基金项目

四川省科技厅软科学项目(2022JDR0325) (2022JDR0325)

中国全科医学

OA北大核心CSTPCD

1007-9572

访问量0
|
下载量0
段落导航相关论文